CYP 1.89% 27.0¢ cynata therapeutics limited

Ann: Initial Results in First 16 DFU Patients Expected in Q1 2024, page-2

  1. Eqz
    3,324 Posts.
    lightbulb Created with Sketch. 1080
    Company has been in the pits for quite some time, trading at cash levels .. market is saying the IP is worthless despite having multiple clinical trials in progress and previous offers of $200M .

    Sucks for exisiting long term holders but prime opportunity for new investors to get in at very attractive risk reward ratio.
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.